Witnessing the stock’s movement on the chart, on Wednesday, Apogee Therapeutics Inc. (NASDAQ: APGE) had a quiet start as it plunged -3.00% to $46.95, before settling in for the price of $48.40 at the close. Taking a more long-term approach, APGE posted a 52-week range of $14.19-$72.29.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that the giant of the Healthcare sector posted annual sales growth of 0.00% over the last 5 years. Nevertheless, stock’s Earnings Per Share (EPS) this year is 16.91%. This publicly-traded company’s shares outstanding now amounts to $37.17 million, simultaneously with a float of $37.12 million. The organization now has a market capitalization sitting at $2.75 billion. At the time of writing, stock’s 50-day Moving Average stood at $45.22, while the 200-day Moving Average is $42.42.
Apogee Therapeutics Inc. (APGE) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Apogee Therapeutics Inc.’s current insider ownership accounts for 36.53%, in contrast to 76.98% institutional ownership. Preceding that transaction, on Aug 23 ’24, Company’s Chief Financial Officer sold 6,000 for 48.26, making the whole transaction’s value amount to 289,560. This particular insider is now the holder of 200,871 in total.
Apogee Therapeutics Inc. (APGE) Earnings and Revenue Records
Apogee Therapeutics Inc.’s EPS increase for this current 12-month fiscal period is 16.91% and is forecasted to reach -3.54 in the upcoming year.
Apogee Therapeutics Inc. (NASDAQ: APGE) Trading Performance Indicators
Let’s observe the current performance indicators for Apogee Therapeutics Inc. (APGE). It’s Quick Ratio in the last reported quarter now stands at 27.70. The Stock has managed to achieve an average true range (ATR) of 2.62.
In the same vein, APGE’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.28, a figure that is expected to reach -0.78 in the next quarter, and analysts are predicting that it will be -3.54 at the market close of one year from today.
Technical Analysis of Apogee Therapeutics Inc. (APGE)
Going through the that latest performance of [Apogee Therapeutics Inc., APGE]. Its last 5-days volume of 0.42 million was inferior to the volume of 0.52 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 48.37% While, its Average True Range was 2.53.
Raw Stochastic average of Apogee Therapeutics Inc. (APGE) in the period of the previous 100 days is set at 48.86%, which indicates a major rise in contrast to 39.41% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 56.38% that was lower than 58.06% volatility it exhibited in the past 100-days period.
